CircGenomics Profile Banner
Circular Genomics Inc. Profile
Circular Genomics Inc.

@CircGenomics

Followers
26
Following
7
Media
88
Statuses
105

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision psychiatry.

Albuquerque, NM
Joined March 2021
Don't wanna be here? Send us removal request.
@CircGenomics
Circular Genomics Inc.
4 days
Circular Genomics has been awarded a $250K investment from the Alzheimer’s Drug Discovery Foundation to advance our circular RNA blood-based early detection diagnostic testing for Alzheimer’s Disease. Read the full press release here:
Tweet media one
0
0
1
@CircGenomics
Circular Genomics Inc.
9 days
🎙️ Hear Dr. Madhukar Trivedi, Professor of Psychiatry at UT Southwestern Medical School, discuss how the MindLight™ Antidepressant Response Test uses circular RNA to help clinicians make more informed treatment decisions — giving patients the best chance at relief, faster.
0
0
0
@CircGenomics
Circular Genomics Inc.
11 days
Treating Major Depressive Disorder is complex, and the current standard often leaves patients waiting weeks to see if treatment works. For physicians, finding the right antidepressant can feel like educated guesswork. But with the MindLight™ Antidepressant Response Test,
0
0
0
@CircGenomics
Circular Genomics Inc.
22 days
We are live at the American Association of Nurse Practitioner meeting! Stop by booth #237 to learn how MindLight can improve treatment planning for patients diagnosed with #MajorDepressiveDisorder. #AANP2025 #PrecisionPsychiatry #MentalHealth
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
25 days
We’re excited to exhibit at the AANP National Conference in San Diego from June 17–22, 2025! Looking forward to connecting with NPs and sharing how genomic innovation is advancing mental health care. Stop by booth 237 to learn more! #AANP2025 #PrecisionPsychiatry #MentalHealth
Tweet media one
0
0
1
@CircGenomics
Circular Genomics Inc.
1 month
Justin T. Brown, PhD, our Senior Director of Business Development, will be attending the BIO International Convention June 16–19, 2025 at the Boston Convention & Exhibition Center. Meet with Justin to discuss partnering with us on circRNA-based Dx! #BIO2025
Tweet media one
0
0
1
@CircGenomics
Circular Genomics Inc.
1 month
We’re thrilled to welcome our Commercial Advisory Board members: Melissa Reilly, JD, MBA; Andrew J. Lechleiter; Laura Viaches; and James Grana, PhD. Their deep expertise across healthcare strategy, growth, and innovation will be invaluable as we advance Circular Genomics’
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
1 month
We are excited to share that our CEO, Paul Sargeant, PhD, will be speaking at the Dubai Family Office Investment Summit on June 12, 2025. He’ll be sharing insights on how innovation in Circular RNA is shaping the future of precision medicine in mental health.
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
1 month
🧠 June is #Alzheimers & #BrainAwareness Month!. Take charge of your brain health: .✔️ Move more.✔️ Sleep better.✔️ Eat smart.✔️ Stay mentally active.✔️ Know the signs. At Circular Genomics, we're advancing brain health through circular RNA & precision medicine. #GoPurple #ENDALZ
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
1 month
June is Men’s Mental Health Awareness Month — a time to bring attention to the unique mental health challenges men face and to break down the stigma surrounding them. Too often, men are encouraged to stay silent about their struggles. But the truth is:.Asking for help is not a
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
1 month
For some patients with #MajorDepressiveDisorder, it can take up to 1 year to find the right treatment. MindLight™ uses circular RNA technology to help predict a patient’s likelihood of response to SSRIs. Learn more:
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
At Circular Genomics, we're pioneering a new era in mental health care. By identifying brain-enriched circRNA biomarkers in blood, we're enabling clinicians to predict patient responses to SSRI antidepressants—moving towards personalized, effective treatment planning.
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
That’s a wrap on #APAAM25! From presenting our research on circular RNA to highlighting the clinical value of the MindLight™ test, our team enjoyed engaging with dedicated healthcare providers who share our mission to advance mental health care.
Tweet media one
Tweet media two
0
0
1
@CircGenomics
Circular Genomics Inc.
2 months
We are live at the #APA2025 meeting! Visit Circular Genomics at Booth #2114 to learn how MindLight can support treatment planning for patients diagnosed with #MajorDepressive Disorder.
Tweet media one
0
0
1
@CircGenomics
Circular Genomics Inc.
2 months
We’re excited to share that Greg Papageorgiou, PhD, our Lab Manager, will be presenting a poster at the American Psychiatric Association (APA) 2025 Annual Meeting. Stop by the poster and booth #2114 to learn more!
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
Today is National Mental Health Provider Appreciation Day 💙. We’re grateful for the dedicated professionals who support individuals living with mental illness. Your compassion, care, and impact matter—today and every day. #MentalHealthProviderAppreciation #ThankYouProviders
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
May is #MentalHealthAwarenessMonth — a time to advocate for more personalized, science-driven care. At Circular Genomics, we’re advancing precision psychiatry for depression & Alzheimer’s by using brain-derived biomarkers to help guide treatment decisions. #MindLight
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
🌟 We’re heading to the American Psychiatric Association 2025 Annual Meeting! . Speak with our team to learn how the MindLight™ test can help stratify patients with major depressive disorder and help inform treatment planning. 📍Visit us at Booth 2114. #APA2025
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
The MindLight Antidepressant Response Test™ uses a simple blood draw to analyze unique circular RNA biomarkers — helping stratify patients with major depressive disorder to predict response to SSRI therapy. Learn more:
Tweet media one
0
0
0
@CircGenomics
Circular Genomics Inc.
2 months
Stratifying patients with #majordepressivedisorder by their likelihood to respond to #SSRIs can lead to faster, more effective treatment—and a better quality of life. Learn how the MindLight™ Antidepressant Response Test supports personalized care:
Tweet media one
0
0
0